Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.34 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LIG1 | P18858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11798219 | 0.72 | MGAM (0.32) | L3MBTL1 | |
| SCHEMBL693560 | 0.72 | — | — | |
| SCHEMBL6279980 | 0.68 | ADRB2 (0.30) | — | |
| SCHEMBL1892027 | 0.67 | MEN1 (0.46) | LMNAL3MBTL1 | |
| SCHEMBL2870616 | 0.67 | L3MBTL1 (0.31) | L3MBTL1 | |
| SCHEMBL14874720 | 0.66 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| Pivalate SCHEMBL9055894 | 0.66 | TDP1 (0.35) | MAPTCACNA1BAPBA1ALDH1A1L3MBTL1 | |
| Pivalate SCHEMBL27810473 | 0.66 | TSHR (0.34) | MAPTCACNA1BAPBA1ALDH1A1TSHR | |
| SCHEMBL10720740 | 0.65 | SMN1; SMN2 (0.37) | MAPTCACNA1BAPBA1ALDH1A1TSHR | |
| SCHEMBL3065421 | 0.65 | L3MBTL1 (0.40) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2120965-B1 | N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES | NOVABAY PHARMACEUTICALS INC (US) | 2014-11-05 | — | — | EP | disclosed |
| EP-2120965-A1 | N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES | Novabay Pharmaceuticals, Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008083347-A1 | N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES | NOVABAY PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | WO | disclosed |